Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-03-02 Purchase |
2021-03-03 5:19 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
3,000 | $16.25 | $48,750 | 4,771,794 (Direct) |
View |
2021-02-26 Purchase |
2021-03-02 4:15 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
5,000 | $16.25 | $81,250 | 4,768,794 (Indirect) |
View |
2021-02-26 Purchase |
2021-03-02 4:15 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
5,000 | $16.25 | $81,250 | 4,768,794 (Direct) |
View |
2021-02-24 Purchase |
2021-02-26 4:05 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
31,000 | $16.48 | $510,862 | 4,763,794 (Indirect) |
View |
2021-02-24 Purchase |
2021-02-26 4:05 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
31,000 | $16.48 | $510,862 | 4,763,794 (Direct) |
View |
2021-02-23 Purchase |
2021-02-25 5:55 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
20,300 | $17.79 | $361,070 | 4,732,794 (Indirect) |
View |
2021-02-23 Purchase |
2021-02-25 5:55 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
20,300 | $17.79 | $361,070 | 4,732,794 (Direct) |
View |
2021-02-22 Purchase |
2021-02-24 8:32 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
9,802 | $18.88 | $185,062 | 4,712,494 (Direct) |
View |
2021-02-22 Purchase |
2021-02-24 8:27 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
9,802 | $18.88 | $185,062 | 4,712,494 (Indirect) |
View |
2021-02-19 Purchase |
2021-02-23 4:15 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
11,786 | $19.77 | $233,009 | 4,702,692 (Indirect) |
View |
2021-02-19 Purchase |
2021-02-23 4:15 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
11,786 | $19.77 | $233,009 | 4,702,692 (Direct) |
View |
2021-02-18 Purchase |
2021-02-19 4:15 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
753 | $19.75 | $14,872 | 4,690,906 (Indirect) |
View |
2021-02-18 Purchase |
2021-02-19 4:15 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
753 | $19.75 | $14,872 | 4,690,906 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-02-08 Conversion |
2021-02-10 6:47 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | RICKS THOMAS G Director |
14,786,774 | $0 | 301,769 (Indirect) |
View |
2021-02-08 Conversion |
2021-02-10 6:46 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
117,959,151 | $0 | 4,690,153 (Indirect) |
View |
2021-02-08 Conversion |
2021-02-10 6:44 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | H&S INVESTMENTS I LP H&S VENTURES LLC SCHULMAN MICHAEL SAMUELI HENRY SAMUELI SUSAN 10% Owner |
213,730,080 | $0 | 4,425,998 (Direct) |
View |
2021-02-08 Conversion |
2021-02-10 6:44 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
7,229,324 | $0 | 4,690,153 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:44 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | Vojta Deneen Director |
16,666 | $0 | 16,666 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:43 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | RICKS THOMAS G Director |
16,666 | $0 | 16,666 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:41 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
16,666 | $0 | 16,666 (Indirect) |
View |
2021-02-03 Option Award |
2021-02-05 4:40 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | Holmen Bob Director |
16,666 | $0 | 16,666 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:40 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | Hoey Anupama Chief Business Officer |
83,333 | $0 | 83,333 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:39 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | Fjaellskog Marie-Louise Chief Medical Officer |
79,166 | $0 | 79,166 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:38 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | Colgan Erin SVP of Finance |
52,083 | $0 | 52,083 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:37 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | Celebi John President & CEO |
416,666 | $0 | 416,666 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:36 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
16,666 | $0 | 16,666 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:35 pm |
N/A 2031-02-02 |
Sensei Biotherapeutics Inc. | SNSE | Broder Samuel Director |
16,666 | $0 | 16,666 (Direct) |
View |
Ownership |
2021-02-03 9:00 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | RICKS THOMAS G Director |
0 | $0 | 14,507,232 (Indirect) |
View |
Ownership |
2021-02-03 8:59 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | Pierce Robert Hamilton Chief Scientific Officer |
0 | $0 | 282,316 (Direct) |
View |
Ownership |
2021-02-03 8:58 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
0 | $0 | 117,854,168 (Indirect) |
View |
Ownership |
2021-02-03 8:57 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | Holmen Bob Director |
0 | $0 | 59,811 (Direct) |
View |
Ownership |
2021-02-03 8:56 pm |
N/A 2030-12-28 |
Sensei Biotherapeutics Inc. | SNSE | Hoey Anupama Chief Business Officer |
0 | $0 | 208,333 (Direct) |
View |
Ownership |
2021-02-03 8:56 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | H&S INVESTMENTS I LP H&S VENTURES LLC SCHULMAN MICHAEL SAMUELI HENRY SAMUELI SUSAN 10% Owner |
0 | $0 | 209,448,032 (Direct) |
View |
Ownership |
2021-02-03 8:54 pm |
N/A 2030-08-04 |
Sensei Biotherapeutics Inc. | SNSE | Fjaellskog Marie-Louise Chief Medical Officer |
0 | $0 | 208,333 (Direct) |
View |
Ownership |
2021-02-03 8:53 pm |
N/A 2030-08-04 |
Sensei Biotherapeutics Inc. | SNSE | Colgan Erin SVP of Finance |
0 | $0 | 62,500 (Direct) |
View |
Ownership |
2021-02-03 8:52 pm |
N/A 2028-04-01 |
Sensei Biotherapeutics Inc. | SNSE | Celebi John President & CEO |
0 | $0 | 586,041 (Direct) |
View |
Ownership |
2021-02-03 8:52 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
0 | $0 | 117,854,168 (Direct) |
View |
Ownership |
2021-02-03 8:51 pm |
N/A 2029-04-04 |
Sensei Biotherapeutics Inc. | SNSE | Broder Samuel Director |
0 | $0 | 20,145 (Direct) |
View |